Hippocampal Avoidance During Prophylactic Cranial Irradiation for Patients With Small Cell Lung Cancer: Randomized Phase II/III Trial NRG-CC003 The 33 eligible patients had a median age of 71 years ...
Mosunetuzumab Plus Polatuzumab Vedotin in Transplant-Ineligible Refractory/Relapsed Large B-Cell Lymphoma: Primary Results of the Phase III SUNMO Trial In the POLARIX study (ClinicalTrials.gov ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback